Clinical approach to severe Clostridium difficile infection: Update for the hospital practitioner

European Journal of Internal Medicine

Volumn 22, Issue 6, 2011, Pages 561-568

  Pant, Chaitanya ^a   Sferra, Thomas J ^a   Deshpande, Abhishek ^b   Minocha, Anil ^c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Clostridium difficile; Fulminant colitis; Metronidazole; Vancomycin

Indexed keywords

METRONIDAZOLE; PROBIOTIC AGENT; VANCOMYCIN;

CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLON RESECTION; ENTERITIS; HEALTH CARE PERSONNEL; HEMODYNAMICS; ILEOSTOMY; IMMUNOTHERAPY; LEUKOCYTE COUNT; PATHOGENESIS; REVIEW;

EID: 80955181168     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.04.009     Document Type: Short Survey

References (124)

1. R.L. Guerrant, J.M. Hughes, N.L. Lima, and J. Crane Diarrhea in developed and developing countries: magnitude, special settings, and etiologies Rev Infect Dis 12 1990 S41 S50
2. L.V. McFarland Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients Am J Infect Control 23 1995 295 305
3. A.R. Salkind Clostridium difficile: an update for the primary care clinician South Med J 103 2010 896 902
4. L. Heinlen, and J.D. Ballard Clostridium difficile infection Am J Med Sci 340 2010 247 252
5. B. Faris, A. Blackmore, and N. Haboubi Review of medical and surgical management of Clostridium difficile infection Tech Coloproctol 14 2010 97 105
6. M.M. Riggs, A.K. Sethi, T.F. Zabarsky, E.C. Eckstein, R.L. Jump, and C.J. Donskey Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents Clin Infect Dis 45 2007 992 998 (Pubitemid 47580347)
7. Steering Group on Healthcare Associated Infections Clostridium difficile infection: how to deal with the problem. A board to ward approach 2008 Department of Health London
8. R. Fekety, and A.B. Shah Diagnosis and treatment of Clostridium difficile colitis JAMA 269 1993 71 75 (Pubitemid 23006526)
9. S.E. Noblett, M. Welfare, and K. Seymour The role of surgery in Clostridium difficile colitis BMJ 338 2009 b1563
10. C. O'Donoghue, and L. Kyne Update on Clostridium difficile infection Curr Opin Gastroenterol 2010
11. A.J. Greenstein, J.C. Byrn, L.P. Zhang, K.A. Swedish, A.E. Jahn, and C.M. Divino Risk factors for the development of fulminant Clostridium difficile colitis Surgery 143 2008 623 629
12. B.W. Hurley, and C.C. Nguyen The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea Arch Intern Med 162 2002 2177 2184 (Pubitemid 35231585)
13. E.A. Sailhamer, K. Carson, Y. Chang, N. Zacharias, K. Spaniolas, and M. Tabbara Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality Arch Surg 144 2009 433 439
14. J. Pepin, L. Valiquette, M.E. Alary, P. Villemure, A. Pelletier, and K. Forget Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity CMAJ 2004 466 472 (Pubitemid 39179608)
15. V.G. Loo, L. Poirier, M.A. Miller, M. Oughton, M.D. Libman, and S. Michaud A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality N Engl J Med 353 2005 2442 2449 (Pubitemid 41770165)
16. L.C. McDonald, G.E. Killgore, A. Thompson, R.C. Owens Jr, S.V. Kazakova, and S.P. Sambol An epidemic, toxin gene-variant strain of Clostridium difficile N Engl J Med 353 2005 2433 2441 (Pubitemid 41770164)
17. M. Warny, J. Pepin, A. Fang, G. Killgore, A. Thompson, and J. Brazier Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe Lancet 366 2005 1079 1084 (Pubitemid 41338761)
18. A.C. Labbe, L. Poirier, D. Maccannell, T. Louie, M. Savoie, and C. Béliveau Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain Antimicrob Agents Chemother 52 2008 3180 3187
19. A. Goorhuis, T. Van der Kooi, N. Vaessen, F.W. Dekker, R. Van den Berg, and C. Harmanus Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands Clin Infect Dis 45 2007 695 703 (Pubitemid 47378882)
20. B. Hubert, V.G. Loo, A.M. Bourgault, L. Poirier, A. Dascal, and E. Fortin A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec Clin Infect Dis 44 2007 238 244 (Pubitemid 46079988)
21. F. Sundram, A. Guyot, I. Carboo, S. Green, M. Lilaonitkul, and A. Scourfield Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors J Hosp Infect 72 2009 111 118
22. V.C. Cheng, W.C. Yam, J.F. Chan, K.K. To, P.L. Ho, and K.Y. Yuen Clostridium difficile ribotype 027 arrives in Hong Kong Int J Antimicrob Agents 34 2009 492 493
23. H. Kato, Y. Ito, R.J. van den Berg, E.J. Kuijper, and Y. Arakawa First isolation of Clostridium difficile 027 in Japan Euro Surveill 12 2007 E070111.3.
24. C.H. Tae, S.A. Jung, H.J. Song, S.E. Kim, H.J. Choi, and M. Lee The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea J Korean Med Sci 4 2009 520 524
25. A. Goorhuis, D. Bakker, J. Corver, S.B. Debast, C. Harmanus, and D.W. Notermans Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078 Clin Infect Dis 47 2008 1162 1170
26. C. Williams, and K.E. McColl Review article: proton pump inhibitors and bacterial overgrowth Aliment Pharmacol Ther 23 2006 3 10 (Pubitemid 43381161)
27. J. Leonard, J.K. Marshall, and P. Moayyedi Systematic review of the risk of enteric infection in patients taking acid suppression Am J Gastroenterol 102 2007 2047 2056 (Pubitemid 47301504)
28. M.A. Miller, M. Hyland, M. Ofner-Agostini, M. Gourdeau, M. Ishak Canadian Hospital Epidemiology Committee Canadian Nosocomial Infection Surveillance P. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals Infect Control Hosp Epidemiol 23 2002 137 140 (Pubitemid 34246541)
29. L.C. McDonald, M. Owings, and D.B. Jernigan Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003 Emerg Infect Dis 12 2006 409 415
30. D.K. Wysowski Increase in deaths related to enterocolitis due to Clostridium difficile in the United States, 1999-2002 Public Health Rep 121 2006 361 362 (Pubitemid 44186393)
31. L.V. McFarland, J.E. Clarridge, H.W. Beneda, and G.J. Raugi Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system Clin Infect Dis 45 2007 1141 1151 (Pubitemid 47580312)
32. M.D. Zilberberg, A.F. Shorr, and M.H. Kollef Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005 Emerg Infect Dis 14 2008 929 931 (Pubitemid 351838602)
33. L. Kyne, M.B. Hamel, R. Polavaram, and C.P. Kelly Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile Clin Infect Dis 34 2002 346 353 (Pubitemid 34062235)
34. J.A. O'Brien, B.J. Lahue, J.J. Caro, and D.M. Davidson The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences Infect Control Hosp Epidemiol 28 2007 1219 1227 (Pubitemid 47596558)
35. L.V. McFarland Renewed interest in a difficult disease: Clostridium difficile infections-epidemiology and current treatment strategies Curr Opin Gastroenterol 25 2009 24 35
36. T. Giesemann, M. Egerer, T. Jank, and K. Aktories Processing of Clostridium difficile toxins J Med Microbiol 57 2008 690 696 (Pubitemid 351842059)
37. A.N. Ananthakrishnan Clostridium difficile infection: epidemiology, risk factors and management Nat Rev Gastroenterol Hepatol 8 2011 17 26
38. I. Tonna, and P.D. Welsby Pathogenesis and treatment of Clostridium difficile infection Postgrad Med J 81 2005 367 369 (Pubitemid 40834901)
39. P. Hookman, and J.S. Barkin Clostridium difficile associated infection, diarrhea and colitis World J Gastroenterol 15 2009 1554 1580
40. J.R. O'Connor, S. Johnson, and D.N. Gerding Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain Gastroenterology 136 2009 1913 1924
41. A. Deshpande, C. Pant, A. Jain, T.G. Fraser, and D.D. Rolston Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence Curr Med Res Opin 24 2008 329 333 (Pubitemid 351294381)
42. M.B. Cohen Clostridium difficile infections: emerging epidemiology and new treatments J Pediatr Gastroenterol Nutr 48 2009 S63 S65
43. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383 (Pubitemid 17055592)
44. C.N. Andrews, J. Raboud, B.O. Kassen, and R. Enns Clostridium difficile-associated diarrhea: predictors of severity in patients presenting to the emergency department Can J Gastroenterol 17 2003 369 373 (Pubitemid 36958164)
45. C. Hardt, T. Berns, W. Treder, and F.L. Dumoulin Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein World J Gastroenterol 14 2008 4338 4341
46. F. Lamontagne, A.C. Labbe, O. Haeck, O. Lesur, M. Lalancette, and C. Patino Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain Ann Surg 245 2007 267 272 (Pubitemid 46148486)
47. J. Pepin, T.T. Vo, M. Boutros, E. Marcotte, S. Dial, and S. Dubé Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection Dis Colon Rectum 52 2009 400 405
48. D. Gujja, and F.K. Friedenberg Predictors of serious complications due to Clostridium difficile infection Aliment Pharmacol Ther 29 2009 635 642
49. T.J. Henrich, D. Krakower, A. Bitton, and D.S. Yokoe Clinical risk factors for severe Clostridium difficile-associated disease Emerg Infect Dis 15 2009 415 422
50. M. Moshkowitz, E. Ben-Baruch, Z. Kline, Z. Shimoni, M. Niven, and F. Konikoff Risk factors for severity and relapse of pseudomembranous colitis in an elderly population Colorectal Dis 9 2007 173 177 (Pubitemid 46111602)
51. J. Pepin, N. Saheb, M.A. Coulombe, M.E. Alary, M.P. Corriveau, and S. Authier Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec Clin Infect Dis 41 2005 1254 1260 (Pubitemid 41532667)
52. A. Bhangu, A. Czapran, S. Bhangu, and D. Pillay Optimum timing of blood tests for monitoring patients with Clostridium difficile-associated diarrhea J Investig Med 58 2010 621 624
53. C. Pant, T.J. Sferra, P.F. Bass, G.V. Burton, and A. Minocha Letter in Response to the Article "Optimum Timing of Blood Tests for Monitoring Patients with Clostridium difficile-Associated Diarrhea" J Investig Med 58 2010 621 624
54. D.J. Riddle, and E.R. Dubberke Clostridium difficile infection in solid organ transplant recipients Curr Opin Organ Transplant 13 2008 592 600
55. E. Blot, M.C. Escande, D. Besson, F. Barbut, C. Granpeix, and B. Asselain Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics J Hosp Infect 53 2003 187 192 (Pubitemid 38002053)
56. M. Schaier, C. Wendt, M. Zeier, and E. Ritz Clostridium difficile diarrhoea in the immunosuppressed patient-update on prevention and management Nephrol Dial Transplant 19 2004 2432 2436 (Pubitemid 39360086)
57. E.R. Dubberke, and D.J. Riddle Clostridium difficile in solid organ transplant recipients Am J Transplant 9 2009 S35 S40
58. E.R. Dubberke, K.A. Reske, A. Srivastava, J. Sadhu, R. Gatti, and R.M. Young Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes Clin Transplant 24 2010 192 198
59. A.N. Ananthakrishnan, M. Issa, and D.G. Binion Clostridium difficile and inflammatory bowel disease Gastroenterol Clin North Am 38 2009 711 728
60. A.N. Ananthakrishnan, E.L. McGinley, and D.G. Binion Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease Gut 57 2008 205 210 (Pubitemid 351158048)
61. S. Ben-Horin, M. Margalit, P. Bossuyt, J. Maul, Y. Shapira, and D. Bojic Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection Clin Gastroenterol Hepatol 7 2009 981 987
62. S.G. Sheth, and J.T. LaMont Gastrointestinal problems in the chronically critically ill patient Clin Chest Med 22 2001 135 147 (Pubitemid 32290600)
63. M.R. Jaber, S. Olafsson, W.L. Fung, and M.E. Reeves Clinical review of the management of fulminant Clostridium difficile infection Am J Gastroenterol 103 2008 3195 3203
64. M. Moyenuddin, J.C. Williamson, and C.A. Ohl Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy Curr Gastroenterol Rep 4 2002 279 286
65. M.J. Crobach, O.M. Dekkers, M.H. Wilcox, and E.J. Kuijper European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI) Clin Microbiol Infect 15 2009 1053 1066
66. K. Eastwood, P. Else, A. Charlett, and M. Wilcox Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods J Clin Microbiol 47 2009 3211 3217
67. G.W. Boland, M.J. Lee, A. Cats, and P.R. Mueller Pseudomembranous colitis: diagnostic sensitivity of the abdominal plain radiograph Clin Radiol 49 1994 473 475 (Pubitemid 24229502)
68. L. Ash, M.E. Baker, C.M. O'Malley Jr., S.M. Gordon, C.P. Delaney, and N.A. Obuchowski Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings AJR Am J Roentgenol 186 2006 1393 1400 (Pubitemid 46112578)
69. I.D. Kirkpatrick, and H.M. Greenberg Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy? AJR Am J Roentgenol 176 2001 635 639 (Pubitemid 32181955)
70. K.N. Jalan, W. Sircus, W.I. Card, C.W. Falconer, C.B. Bruce, and G.P. Crean An experience of ulcerative colitis. I. Toxic dilation in 55 cases Gastroenterology 57 1969 68 82
71. L. Sayedy, D. Kothari, and R.J. Richards Toxic megacolon associated Clostridium difficile colitis World J Gastrointest Endosc 2 2010 293 297
72. M. Issa, A. Vijayapal, M.B. Graham, D.B. Beaulieu, M.F. Otterson, and S. Lundeen Impact of Clostridium difficile on inflammatory bowel disease Clin Gastroenterol Hepatol 5 2007 345 351 (Pubitemid 46401531)
73. K. Nomura, Y. Fujimoto, M. Yamashita, Y. Morimoto, M. Ohshiro, and K. Sato Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents Scand J Gastroenterol 44 2009 74 78
74. E. Mylonakis, E.T. Ryan, and S.B. Calderwood Clostridium difficile-associated diarrhea: a review Arch Intern Med 161 2001 525 533 (Pubitemid 32167517)
75. C.P. Kelly, and J.T. LaMont Clostridium difficile-more difficult than ever N Engl J Med 359 2008 1932 1940
76. S.H. Cohen, D.N. Gerding, S. Johnson, C.P. Kelly, V.G. Loo, and L.C. McDonald Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA) Infect Control Hosp Epidemiol 31 2010 431 455
77. H.L. Koo, D.C. Koo, D.M. Musher, and H.L. DuPont Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis Clin Infect Dis 48 2009 598 605
78. J.G. Bartlett The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection Clin Infect Dis 46 2008 1489 1492 (Pubitemid 351706727)
79. H. Martin, B. Willey, D.E. Low, H.R. Staempfli, A. McGeer, and P. Boerlin Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006 J Clin Microbiol 46 2008 2999 3004
80. T.J. Louie, J. Peppe, C.K. Watt, D. Johnson, R. Mohammed, and G. Dow Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea Clin Infect Dis 43 2006 411 420 (Pubitemid 44157147)
81. F.A. Zar, S.R. Bakkanagari, K.M. Moorthi, and M.B. Davis A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity Clin Infect Dis 45 2007 302 307 (Pubitemid 47101025)
82. J. Pepin Vancomycin for the treatment of Clostridium difficile infection: for whom is this expensive bullet really magic? Clin Infect Dis 46 2008 1493 1498 (Pubitemid 351706728)
83. J.G. Bartlett Clinical practice. Antibiotic-associated diarrhea N Engl J Med 346 2002 334 339
84. F.J. Tedesco, D. Gordon, and W.C. Fortson Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis Am J Gastroenterol 80 1985 867 868 (Pubitemid 16233533)
85. A. Apisarnthanarak, B. Razavi, and L.M. Mundy Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature Clin Infect Dis 35 2002 690 696 (Pubitemid 35024729)
86. J.G. Bublin, and T.L. Barton Rectal use of vancomycin Ann Pharmacother 28 1994 1357 1358
87. M. Pasic, R. Jost, T. Carrel, L. Von Segesser, and M. Turina Intracolonic vancomycin for pseudomembranous colitis N Engl J Med 329 1993 583
88. J.G. Bartlett New antimicrobial agents for patients with Clostridium difficile infections Curr Infect Dis Rep 11 2009 21 28
89. J.W. Shin, D. Yong, M.S. Kim, K.H. Chang, K. Lee, and J.M. Kim Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin J Infect Chemother 9 2003 62 67 (Pubitemid 36504373)
90. R. Nelson Antibiotic treatment for Clostridium difficile-associated diarrhea in adults Cochrane Database Syst Rev 3 2007 CD004610.
91. B.L. Herpers, B. Vlaminckx, O. Burkhardt, H. Blom, H.S. Biemond-Moeniralam, and M. Hornef Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection Clin Infect Dis 48 2009 1732 1735
92. M. Miller Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection Expert Opin Pharmacother 11 2010 1569 1578
93. T.J. Louie, M.A. Miller, K.M. Mullane, K. Weiss, A. Lentnek, and Y. Golan Fidaxomicin versus vancomycin for Clostridium difficile infection N Engl J Med 364 2011 422 431
94. A. Pillai, and R. Nelson Probiotics for treatment of Clostridium difficile-associated colitis in adults Cochrane Database Syst Rev 1 2008 CD004611.
95. D.D. Hedge, J.D. Strain, J.R. Heins, and D.K. Farver New advances in the treatment of Clostridium difficile infection (CDI) Ther Clin Risk Manag 4 2008 949 964
96. S.D. Baines, J. Freeman, and M.H. Wilcox Tolevamer is not efficacious in the neutralization of cytotoxin in a human gut model of Clostridium difficile infection Antimicrob Agents Chemother 53 2009 2202 2204
97. N.T. Williams Probiotics Am J Health Syst Pharm 67 2010 449 458
98. L.V. McFarland Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections Anaerobe 15 2009 274 280
99. I. Castagliuolo, M.F. Riegler, L. Valenick, J.T. LaMont, and C. Pothoulakis Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa Infect Immun 67 1999 302 307 (Pubitemid 29021663)
100. N. Dendukuri, V. Costa, M. McGregor, and J.M. Brophy Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review CMAJ 173 2005 167 170 (Pubitemid 41032513)
101. S.C. Singhi, and A. Baranwal Probiotic use in the critically ill Indian J Pediatr 75 2008 621 627
102. M.P. Bauer, J.T. van Dissel, and E.J. Kuijper Clostridium difficile: controversies and approaches to management Curr Opin Infect Dis 22 2009 517 524
103. M.S. Abougergi, A. Broor, W. Cui, and B.G. Jaar Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature J Hosp Med 5 2010 E1 E9
104. J. O'Horo, and N. Safdar The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review Int J Infect Dis 13 2009 663 667
105. I. Lowy, D.C. Molrine, B.A. Leav, B.M. Blair, R. Baxter, and D.N. Gerding Treatment with monoclonal antibodies against Clostridium difficile toxins N Engl J Med 362 2010 197 205
106. J.S. Bakken Fecal bacteriotherapy for recurrent Clostridium difficile infection Anaerobe 15 2009 285 289
107. S.S. Yoon, and L.J. Brandt Treatment of Refractory/Recurrent C. difficile-associated Disease by Donated Stool Transplanted Via Colonoscopy: A Case Series of 12 Patients J Clin Gastroenterol 2010
108. T.J. Borody "Flora Power"-fecal bacteria cure chronic C. difficile diarrhea Am J Gastroenterol 95 2000 3028 3029
109. A. Gustafsson, S. Lund-Tonnesen, A. Berstad, T. Midtvedt, and E. Norin Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment Scand J Gastroenterol 33 1998 721 727 (Pubitemid 28358056)
110. D.M. You, M.A. Franzos, and R.P. Holman Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy Ann Intern Med 148 2008 632 633 (Pubitemid 351669152)
111. K. Synnott, K. Mealy, C. Merry, L. Kyne, C. Keane, and R. Quill Timing of surgery for fulminating pseudomembranous colitis Br J Surg 85 1998 229 231 (Pubitemid 28099945)
112. S.O. Ali, J.P. Welch, and R.J. Dring Early surgical intervention for fulminant pseudomembranous colitis Am Surg 74 2008 20 26 (Pubitemid 351396878)
113. J.C. Byrn, D.C. Maun, D.S. Gingold, D.T. Baril, J.J. Ozao, and C.M. Divino Predictors of mortality after colectomy for fulminant Clostridium difficile colitis Arch Surg 143 2008 150 154 (Pubitemid 351281618)
114. J.F. Hall, and D. Berger Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management Am J Surg 196 2008 384 388
115. W.E. Longo, J.E. Mazuski, K.S. Virgo, P. Lee, A.N. Bahadursingh, and F.E. Johnson Outcome after colectomy for Clostridium difficile colitis Dis Colon Rectum 47 2004 1620 1626 (Pubitemid 39331972)
116. C.W. Seder, M.R. Villalba Jr., J. Robbins, F.A. Ivascu, C.F. Carpenter, and M. Dietrich Early colectomy may be associated with improved survival in fulminant Clostridium difficile colitis: an 8-year experience Am J Surg 197 2009 302 307
117. A.D. Perera, R.P. Akbari, M.S. Cowher, T.E. Read, J.T. McCormick, and D.S. Medich Colectomy for fulminant Clostridium difficile colitis: predictors of mortality Am Surg 76 2010 418 421
118. P. Butala, and C.M. Divino Surgical aspects of fulminant Clostridium difficile Colitis Am J Surg 2010
119. G.G. Kaplan, E.P. McCarthy, J.Z. Ayanian, J. Korzenik, R. Hodin, and B.E. Sands Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis Gastroenterology 134 2008 680 687
120. H. Dudukgian, E. Sie, C. Gonzalez-Ruiz, D.A. Etzioni, and A.M. Kaiser C. difficile colitis-predictors of fatal outcome J Gastrointest Surg 14 2010 315 322
121. K. Koss, M.A. Clark, D.S. Sanders, D. Morton, M.R. Keighley, and J. Goh The outcome of surgery in fulminant Clostridium difficile colitis Colorectal Dis 8 2006 149 154 (Pubitemid 43372465)
122. J.D. Stanley, and R.P. Burns Clostridium difficile and the surgeon Am Surg 76 2010 235 244
123. A.D. Olivas, K. Umanskiy, B. Zuckerbraun, and J.C. Alverdy Avoiding colectomy during surgical management of fulminant clostridium difficile colitis Surg Infect 11 2010 299 305
124. A.T. Miller, P. Tabrizian, A.J. Greenstein, A. Dikman, J. Byrn, and C. Divino Long-term follow-up of patients with fulminant Clostridium difficile colitis J Gastrointest Surg 13 2009 956 959